Adma Biologics (ADMA) Interest & Investment Income (2011 - 2025)
Adma Biologics (ADMA) posted Interest & Investment Income of $487000.0 for Q4 2025, up 29.52% on a QoQ basis from $376000.0 in Q3 2025, and down 18.56% year-over-year from $598000.0 in Q4 2024.
Adma Biologics (ADMA) Interest & Investment Income (2011 - 2025) Analysis & Trends
Adma Biologics' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $487000.0 for Q4 2025.
- Quarterly Interest & Investment Income fell 18.56% year-over-year to $487000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 10.78% YoY) and the FY2025 annual result came in at $1.9 million, down 10.78% from the prior year.
- Interest & Investment Income was $487000.0 for Q4 2025 at Adma Biologics, up from $376000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $666000.0 in Q3 2024 and bottomed at $2269.0 in Q2 2022.
- A 5-year average of $283150.0 and a median of $380000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income sank 91.11% — and 2023, when it soared 25116.32%.
- Adma Biologics' Interest & Investment Income stood at $2759.0 in 2021, then slipped by 12.03% to $2427.0 in 2022, then surged by 25116.32% to $612000.0 in 2023, then decreased by 2.29% to $598000.0 in 2024, then fell by 18.56% to $487000.0 in 2025.
- Business Quant data shows ADMA's Interest & Investment Income at $487000.0 in Q4 2025, $376000.0 in Q3 2025, and $400000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Adma Biologics | 2.04 Bn | 1.95 Bn | 88.82 Mn | 487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 608,000.00 |
| Dec 31, 2024 | 598,000.00 |
| Sep 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 384,000.00 |
| Dec 31, 2023 | 612,000.00 |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 414,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 2,427.00 |
| Sep 30, 2022 | 7,236.00 |
| Jun 30, 2022 | 2,269.00 |
| Mar 31, 2022 | 33,068.00 |
| Dec 31, 2021 | 2,759.00 |
| Sep 30, 2021 | 4,256.00 |
| Jun 30, 2021 | 5,926.00 |
| Mar 31, 2021 | 22,059.00 |